In Brief This Week:, Bio-Techne, DermTech, Cue Health, DiaSorin, Devyser, More
News items for the week of Feb. 27, 2023.
In Brief This Week: Fujifilm, BD, PerkinElmer, OpGen, More
News items for the week of Jan. 23, 2023.
In Brief This Week: Biocartis, Quest Diagnostics, OpGen, More
News items for the week of Jan. 16, 2023.
MDx Firm OpGen Prices $7.5M Public Offering
The Maryland-based firm announced the public offering of common stock and warrants one day after announcing a 1-for-20 reverse stock split to help regain Nasdaq compliance.
OpGen Announces 1-for-20 Reverse Stock Split
The molecular diagnostics firm recently reported a sharp decline in third quarter revenues amid an increased net loss.
Sep 30, 2022
OpGen to Raise $3.4M in Direct Stock Offering
Sep 20, 2022
FIND, Curetis Ink R&D Collaboration Agreement
Mar 30, 2022
OpGen Q4 Revenues Flat on Modest Product Sale Gains
Nov 12, 2021
OpGen Q3 Revenues Climb 9 Percent
Aug 12, 2021